157 related articles for article (PubMed ID: 6759334)
41. [Clinical effect and transfer into the wound exudate of cefroxadine used in the treatment of soft tissue infection].
Takata N; Yamada T; Kubota T; Kaneko T
Jpn J Antibiot; 1983 Sep; 36(9):2529-34. PubMed ID: 6655867
[TBL] [Abstract][Full Text] [Related]
42. [Clinical use of cefroxadine in dentistry and oral surgery].
Kikuta T; Masuda N; Kinebuchi T; Takarada H
Jpn J Antibiot; 1983 Aug; 36(8):2017-28. PubMed ID: 6655824
[TBL] [Abstract][Full Text] [Related]
43. [Clinical pharmacologic studies of cephalexin. Influence of renal insufficiency, with or without hemodialytic treatment, on plasma levels. Effectiveness in urinary infection].
Zech P; Monnier C; Moskovtchenko JF; Traeger J
Therapeutique; 1971 Dec; 47(10):885-90. PubMed ID: 5145555
[No Abstract] [Full Text] [Related]
44. [Therapeutic efficacy of cefalexin in internal medicine].
Lechi A; Cecchetin M
Clin Ter; 1972 Mar; 60(5):439-47. PubMed ID: 5038776
[No Abstract] [Full Text] [Related]
45. [Fundamental and clinical studies of cefroxadine in pediatric field (author's transl)].
Toyonaga Y; Kurosu Y; Hori M; Kohno S
Jpn J Antibiot; 1981 Dec; 34(12):1608-25. PubMed ID: 7334586
[TBL] [Abstract][Full Text] [Related]
46. Cephradine and cephalexin in the treatment of children with bacterial pneumonia.
Alban J; Caloza DL
Curr Ther Res Clin Exp; 1975 Oct; 18(4):539-45. PubMed ID: 241608
[No Abstract] [Full Text] [Related]
47. Cefroxadine (CGP-9000), an orally active cephalosporin.
Yasuda K; Kurashige S; Mitsuhashi S
Antimicrob Agents Chemother; 1980 Jul; 18(1):105-10. PubMed ID: 6998373
[TBL] [Abstract][Full Text] [Related]
48. Comparison of cephradine and cephalothin in the treatment of urinary tract infections.
Caloza DL; Losi MJ; Fields LA
N C Med J; 1977 Oct; 38(10):597-600. PubMed ID: 335255
[No Abstract] [Full Text] [Related]
49. [Clinical evaluation of cefroxadine in bacterial infections of the eye].
Ooishi M; Nagai S; Nishizuka K; Tanaka R; Takagi K; Hara J; Tanaka Y; Ichihashi K; Hirose Y; Akashi N
Jpn J Antibiot; 1983 Sep; 36(9):2635-64. PubMed ID: 6655872
[TBL] [Abstract][Full Text] [Related]
50. Cefroxadine in the treatment of children affected by respiratory and ENT diseases. A multicentre study involving 1072 in-patients.
Scaglione F; Cattaneo G; Bianchi MM; Verdecchia P; Maresca V; Bichisao E; Fraschini F
Drugs Exp Clin Res; 1989; 15(2):71-6. PubMed ID: 2737082
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of cefovecin for the treatment of urinary tract infections in cats.
Passmore CA; Sherington J; Stegemann MR
J Small Anim Pract; 2008 Jun; 49(6):295-301. PubMed ID: 18422501
[TBL] [Abstract][Full Text] [Related]
52. [Laboratory and clinical studies of cefroxadine (author's transl)].
Nishimura T; Tabuki K; Hiromatsu K; Takashima T; Kotani Y
Jpn J Antibiot; 1981 Dec; 34(12):1634-46. PubMed ID: 7334588
[TBL] [Abstract][Full Text] [Related]
53. [Trial of use of a new oral antibiotic: cephalexin in granules in 59 children].
Bovier-Lapierre M; David M; Lauras B
Lyon Med; 1971 Dec; 226(20):895-900. PubMed ID: 5144397
[No Abstract] [Full Text] [Related]
54. [Comparative studies of the efficacy, safety and usefulness of S6472, cefaclor and cephalexin on complicated urinary tract infection by the double-blind method].
Kamidono S; Arakawa S; Fujii A; Kataoka N; Umezu K; Ishigami J; Hirooka K; Shimatani N; Matsushita M; Hikosaka K
Jpn J Antibiot; 1985 Oct; 38(10):2735-69. PubMed ID: 3908727
[TBL] [Abstract][Full Text] [Related]
55. An overview of results of world-wide clinical trials with cefadroxil.
Santella PJ; Tanrisever B; Berman E
J Int Med Res; 1978; 6(6):441-51. PubMed ID: 363481
[TBL] [Abstract][Full Text] [Related]
56. [Cephradine in urology].
Hutschenreiter G; Klippel KF
MMW Munch Med Wochenschr; 1977 Nov; 119(47):1539-40. PubMed ID: 414092
[No Abstract] [Full Text] [Related]
57. Cefadroxil. A review of its antibacterial, pharmacokinetic and therapeutic properties in comparison with cephalexin and cephradine.
Tanrisever B; Santella PJ
Drugs; 1986; 32 Suppl 3():1-16. PubMed ID: 3542485
[TBL] [Abstract][Full Text] [Related]
58. Antibacterial effects of cefroxadine, cephalexin and cephradine in a new in vitro pharmacokinetic model.
Schneider P; Tosch W; Maurer M; Zak O
J Antibiot (Tokyo); 1982 Jul; 35(7):843-9. PubMed ID: 7174537
[TBL] [Abstract][Full Text] [Related]
59. Double-blind comparison of carbenicillin indanyl sodium, ampicillin, and cephalexin in treatment of urinary tract infection.
Ries KM; Cobbs CG; Gillenwater JY; Levison ME; Mandell GL; Sande MA; Kaye D
Antimicrob Agents Chemother; 1973 Dec; 4(6):593-6. PubMed ID: 4602827
[TBL] [Abstract][Full Text] [Related]
60. [Clinical experience with cephradine].
Ughy E
MMW Munch Med Wochenschr; 1977 Aug; 119(34):1093-4. PubMed ID: 408658
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
